Logo
Logo


ISSN: 0300-9041
ISSNe: 2594-2034


Indizada en: SciELO, Índice Médico Latinoamericano, LILACS, Medline
Editada por la Federación Mexicana de Colegios de Obstetricia, y Ginecologia AC
Fundada por la Asociación Mexicana de Ginecología y Obstetricia en 1945
 

INFORMACIÓN EXCLUSIVA PARA LOS PROFESIONALES DE LA SALUD


Periodicidad: continua
Abreviatura: Ginecol Obstet Mex
ISSN: 0300-9041
ISSNe: 2594-2034
Indizada en: Scimago, Índice Médico Latinoamericano, Lilacs, Medline, Science Citation Index, Ulrich, Ebsco.

Rendimiento diagnóstico del ultrasonido del primer trimestre para alteraciones estructurales

Diagnostic performance of the first trimester ultrasound for structural anomalies.

Ginecol Obstet Mex. 2021; 89 (1): 5-13.

https://doi.org/10.24245/gom.v89i1.3540

Gabriela del Carmen Núñez-Sánchez,1 Juan Manuel Gallardo-Gaona,2 Berenice Velázquez-Torres,2 Dulce María Camarena-Cabrera,2 Sandra Acevedo-Gallegos,2 José Antonio Ramírez-Calvo2

1 Residente de Medicina Materno Fetal.
2 Médico adscrito al Departamento de Medicina.
Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Ciudad de México.


Corrrespondencia:

Juan Manuel Gallardo Gaona
gallarfetalmed@gmail.com

Debe citarse como:

Núñez-Sánchez GC, Gallardo-Gaona JM, Velázquez-Torres B, Camarena-Cabrera DM, Acevedo-Gallegos S, Ramírez-Calvo JA. Rendimiento diagnóstico del ultrasonido del primer trimestre para alteraciones estructurales. Ginecol Obstet Mex. 2021; 89 (1): 5-13. https://doi.org/10.24245/gom.v89i1.3540

Resumen

OBJETIVO: Evaluar el rendimiento diagnóstico del ultrasonido del primer trimestre en la identificación de defectos estructurales detectables y potencialmente detectables en esta etapa de la gestación.

MATERIALES Y MÉTODOS: Estudio  transversal y descriptivo llevado a cabo en el  Departamento de Medicina Materno Fetal del Instituto Nacional de Perinatología Isidro Espinosa de los Reyes entre marzo de 2017 y octubre de 2018. Criterio de inclusión: pacientes que acudieron al ultrasonido de tamizaje del primer trimestre y se les efectuó la evaluación anatómica fetal temprana. Se realizó un estudio tipo prueba diagnóstica con cálculo de índices diagnósticos.

RESULTADOS: Se encontraron 1652 ultrasonidos del primer trimestre en los que la prevalencia de defectos estructurales fue de 2%. Debido a circunstancias ajenas a la investigación solo pudo aplicarse el patrón de referencia a 1610 pacientes de las que se obtuvo una tasa de detección de 83.62% de alteraciones estructurales y especificidad del 100% con el ultrasonido del primer trimestre.

CONCLUSIÓN: El ultrasonido del primer trimestre es ideal para practicar la primera evaluación anatómica fetal, con alta aceptación entre pacientes y médicos. Este estudio no sustituye sino más bien complementa la valoración morfológica fetal que se realiza en el segundo trimestre; al conjuntar ambas valoraciones la sensibilidad es superior a 90% para detectar alteraciones estructurales.

PALABRAS CLAVE: Ultrasonido del primer trimestre; embarazo; tamizaje del primer trimestre; prueba diagnóstica; perinatología; ultrasonografía.

Abstract

OBJECTIVE: To evaluate the diagnostic performance of first trimester ultrasound in the identification of structural defects that are detectable and potentially detectable at this stage of gestation.

MATERIALS AND METHODS: Transversal and descriptive study carried out at the Maternal-Fetal Medicine Department of the Instituto Nacional de Perinatología Isidro Espinosa de los Reyes between March 2017 and October 2018. Inclusion criteria: Patients who attended the first trimester screening ultrasound and underwent early fetal anatomical evaluation. A diagnostic test-type study with calculation of diagnostic indices was performed.

RESULTS: 1652 first-trimester ultrasounds were found in which the prevalence of structural defects was 2%. Due to circumstances beyond the research, the gold standard could only be applied to 1610 patients from whom a detection rate of 83.62% of structural alterations and 100% specificity was obtained with the first-trimester ultrasound.

CONCLUSION: The first-trimester ultrasound is ideal for performing the first fetal anatomical evaluation, with high acceptance among patients and physicians. This study does not replace but rather complements the fetal morphological assessment carried out in the second trimester; by combining both assessments the sensitivity is over 90% for detecting structural alterations.

KEYWORDS: First trimester ultrasound; Gestation; First trimester screening; Diagnostic test; Perinatology; Ultrasonography.

    1. Liff I, Bromley B. Fetal anatomic imaging between 11 and 14 gestation. Clin Obstet Gynecol. 2017; 60 (3): 621-635. https://doi.org/10.1097/GRF.0000000000000296.
    2. ACOG Practice Bulletin No. 163: screening for fetal aneuploidy. Obstet Gynecol. 2016;127. doi. 10.1097/AOG.0000000000001406.
    3. Liff I, Bromley B. Fetal Anatomic Imaging Between 11 and 14 Weeks Gestation. Vol. 60, Clinical Obstet and Gyneco. 2017; 60 (3). https://doi.org/10.1097/GRF.0000000000000296.
    4. McAuliffe FM, Fong KW, Toi A, Chitayat D, Keating S, Johnson JA. Ultrasound detection of fetal anomalies in conjunction with first-trimester nuchal translucency screening: A feasibility study. Am J Obstet Gynecol 2005; 1260-5. https://doi.org/10.1016/j.ajog.2005.06.075.
    5. Donnelly JC, Malone FD. Early fetal anatomical sonography. Vol. 26, Best Practice & Research Clinical Obstetrics & Gynaecology. 2012; 26 (5): 561-73. https://doi.org/10.1016/j.bpobgyn.2012.06.002.
    6. Edwards L, Hui L. First and second trimester screening for fetal structural anomalies. Seminars in Fetal & Neonatal Medicine 2017; 23 (2): 102-11. https://doi.org/10.1016/j.siny.2017.11.005.
    7. Syngelaki A, Chelemen T, Dagklis T, Allan L, Nicolaides KH. Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11-13 weeks. Prenatal Diagn. 2011; 31: 90-102. https://doi.org/10.1002/pd.2642.
    8. Borrell A, Robinson J, Santolaya-Forgas J. Clinical value of the 11- to 13 6-week sonogram for detection of congenital malformations: A Review. Am J Perinatol 2011; 28: 117-24. doi.10.1055/s-0030-1263302.
    9. Kenkhuis MJA, Bakker M, Bardi F, Fontanella F, Fleurke-Rozema JH. Effectiveness of 12-13-week scan for early diagnosis of fetal congenital anomalies in the cell-free DNA era. Ultrasound Obstet Gynecol. 2018 Apr;51(4):463-69. https://doi.org/10.1002/uog.17487
    10. Karim JN, Roberts NW, Salomon LJ, Papageorghiou AT. Systematic review of first-trimester ultrasound screening for detection of fetal structural anomalies and factors that affect screening performance. Ultrasound Obstet Gynecol 2017; 50: 429-41. https://doi.org/10.1002/uog.17246.
    11. Gutiérrez-Gutiérrez H, Velázquez-Torres B. Eficacia de detección de defectos estructurales con ultrasonido de la semana 11 a la 13.6 de gestación. Tesis para obtener el título de especialista en Medicina Materno fetal. Instituto Nacional de Perinatología, Ciudad de México.
    12. Bardi F, Smith E, Kuilman M, Snijders RJM, Bilardo CM. Early detection of structural anomalies in a primary care setting in the Netherlands. Fetal Diagn Ther 2019; 46: 12-19. https://doi.org/10.1159/000490723.
    13. Sonek JD, Kagan KO, Nicolaides KH. Inverted pyramid of care. Clinics in Laboratory Medicine. 2016; 36: 305-17. doi.10.1016/j.cll.2016.01.009.
    14. Yagel S, Achiron R, Ron M, Revel A, Anteb E. Transvaginal ultrasonography at early pregnancy cannot be used alone for targeted organ ultrasonographic examination in a high-risk population. J of Diagnostic Medical Sonography. 1995; 272-3. https://doi.org/10.1016/0002-9378(95)90029-2
    15. Westin M, Saltvedt S, Bergman G, Kublickas M, Almstrom H, Grunewald C, et al. Routine ultrasound examination at 12 or 18 gestational weeks for prenatal detection of major congenital heart malformations? A randomised controlled trial comprising 36 299 fetuses. Vol. 113, BJOG: An International J of Obstet and Gynaecol. 2006; 675-82. https://doi.org/10.1111/j.1471-0528.2006.00951.x.
    16. Lim J, Whittle WL, Lee YM, Ryan G, Van Mieghem T. Early anatomy ultrasound in women at increased risk of fetal anomalies. Prenat Diagn 2013 Sep;33(9):863-8. https://doi.org/10.1002/pd.4145
    17. Volpe P, Ubaldo P, Volpe N, Campobasso G, De Robertis V, Tempesta A, et al. Fetal cardiac evaluation at 11-14 weeks by experienced obstetricians in a low-risk population. Prenat Diagn. 2011; 31: 1054-61. https://doi.org/10.1002/pd.2831
    18. García Fernández S, JArenas Ramírez J, Otero Chouza MT, Rodríguez Vijande B, et al. Early fetal ultrasound screening for major congenital heart defects without Doppler. European Journal of Obstetrics & Gynecology and Reproductive Biology 2019; 233: 93-97. https://doi.org/10.1016/j.ejogrb.2018.11.030
    19. Hernandez-Andrade E. Patwardhan M. Early Evaluation of the Fetal Heart. Fetal Diagn Ther 2017; 42:161-173. https://doi.org/10.1159/000477564
    20. Petousis S, Sotidiaris A, Margioula-Starkou Ch, et al. Detection of structural abnormalities in fetuses with normal karyotype at 11-13 weeks using the anatomic examination protocol of the International Society of Ultrasound in Obstet and Gynecology (ISUOG). J Matern Fetal Neonatal Med. 2019:1-7. https://doi.org/10.1080/14767058.2018.1555807
    21. Vayna AM, Veduta A. Diagnosis of Fetal Structural Anomalies at 11 to 14 Weeks. J Ultrasound Med. 2018; 37 (8): 2063-73. https://doi.org/10.1002/jum.14561.
    22. Becker R, Wegner RD. Detailed screening for fetal anomalies and cardiac defects at the 11-13-week scan. Ultrasound Obstet Gynecol. 2006; 27 (6): 613-18. https://doi.org/10.1002/uog.2709.
    23. Kenkhuis MJA, Bakker M, Bardi F, Fontanella F, et al. Effectiveness of 12-13-week scan for early diagnosis of fetal congenital anomalies in the cell-free DNA era. Ultrasound Obstet Gynecol. 2018; 52 (4): 550. https://doi.org/10.1002/uog.17487.
    24. Dulgheroff FF, Peixoto AB, Galvao Petrini C, Rodrigues da Cunha Caldas TC, Rocha Ramos D, Oliveira Magalhaes F, Araujo Júnior E. Fetal structural anomalies diagnosed during the first, second and third trimesters of pregnancy using ultrasonography: a retrospective cohort study. Sao Paulo Med J. 2019;137(5):391-400. http://dx.doi.org/10.1590/1516-3180.2019.026906082019.

Comentarios